Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000166485 | SCV000217284 | likely benign | Hereditary cancer-predisposing syndrome | 2014-10-25 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001721082 | SCV000528320 | likely benign | not provided | 2019-12-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000476448 | SCV000558285 | likely benign | Ataxia-telangiectasia syndrome | 2024-07-30 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000166485 | SCV000904613 | likely benign | Hereditary cancer-predisposing syndrome | 2017-12-11 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000427026 | SCV001437360 | likely benign | not specified | 2020-09-25 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003491907 | SCV004240735 | likely benign | Breast and/or ovarian cancer | 2022-11-14 | criteria provided, single submitter | clinical testing |